Ben Lynch
Preliminary data published in June 2023 also suggests that GLP-1 drugs 'could modulate crucial pathways in the pathogenesis of inflammatory bowel disease (IBD), such as chronic inflammation circuits, intestinal tight junctions, and gut microbiome dysbiosis, setting the stage for human trials to investigate the role of these agents in the treatment of IBD among people with or without diabetes and obesity' (Arvanitakis, Theocharis, Popovic
Karakuyu NF, zseven A, Akn SE, ama HE, zmen , Cengiz
WARNING: Consuming this product can expose you to chemicals including Lead which is known to the State of California to cause cancer and birth defects or other reproductive harm
These are generally dose-dependent and resolve with proper dosing adjustment
No case reports document this happening, but the mechanistic concern is real enough to warrant disclosure